A dietary fat excess alters metabolic and neuroendocrine responses before the onset of metabolic diseases.
Early changes in neuroendocrine pathways are essential in the development of metabolic pathologies. Thus, it is important to have a better understanding of the signals involved in their initiation. Long-term consumption of high-fat diets induces insulin resistance, obesity, diabetes. Here, we have investigated early neural and endocrine events in the hypothalamus and hippocampus induced by a short-term high fat, low carbohydrate diet in adult male Wistar rats. The release of serotonin, which is closely associated with the actions of insulin and leptin, was measured, by electrochemical detection following reverse-phase liquid chromatography (HPLC), in the extracellular space of the medial hypothalamus and the dorsal hippocampus in samples obtained from non-anesthetized animals, by microdialysis. The high-fat diet had a specific effect on the hypothalamus. Serotonin release induced by food intake was reduced after 1 week, and effectively ceased after 6 weeks of the diet. After 1 week, there was an increased gene expression of the insulin receptor and the insulin receptor substrates IRS1 and IRS2, as measured by real-time PCR. After 6 weeks of diet, insulin gene expression increased. Leptinemia increased in all cases. This new data support the concept that high-fat diets, in addition to have peripheral effects, cause a rapid alteration in specific central mechanisms involved in energy and glucose homeostasis. The changes in the gene expression of insulin and signaling elements represent possible adaptations aimed at counterbalancing the reduced responsiveness of the serotonergic system to nutritional signals and maintaining homeostasis.
Banas
Sophie M
SM
CNRS UMR 7059, University Paris 7, 2 place Jussieu, case 7126, 75251 Paris, France.
Rouch
Claude
C
Kassis
Nadim
N
Markaki
Eirini M
EM
Gerozissis
Kyriaki
K
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D004041:Dietary Fats / Q000009:adverse effects*; D004195:Disease Models, Animal; D004734:Energy Metabolism / Q000502:physiology; D005947:Glucose / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism / Q000503:physiopathology; D006706:Homeostasis / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism*; D055504:Insulin Receptor Substrate Proteins / Q000235:genetics; D008297:Male; D008659:Metabolic Diseases / Q000378:metabolism* / Q000503:physiopathology; D009490:Neurosecretory Systems / Q000378:metabolism* / Q000503:physiopathology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011972:Receptor, Insulin / Q000235:genetics; D012701:Serotonin / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology
D004041:Dietary Fats; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C526296:Irs1 protein, rat; C526299:Irs2 protein, rat; D012333:RNA, Messenger; D012701:Serotonin; D011972:Receptor, Insulin; D005947:Glucose
Nucleic Acids Res. 2002 May 1;30(9):e36
11972351
Science. 2005 Jan 21;307(5708):375-9
15662002
J Alzheimers Dis. 2005 Feb;7(1):63-80
15750215
Behav Brain Res. 2001 Dec 14;127(1-2):13-23
11718882
Endocrinology. 2005 Feb;146(2):913-9
15550507
Regul Pept. 2003 Aug 15;115(1):11-8
12873793
Endocrinology. 2005 Mar;146(3):1576-87
15591151
Exp Biol Med (Maywood). 2008 Jun;233(6):674-88
18408140
Eur J Pharmacol. 2008 May 6;585(1):38-49
18407262
Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E148-54
15353406
Neuroscience. 1997 Oct;80(4):1033-40
9284058
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R981-6
15604298
J Clin Invest. 2004 Oct;114(7):908-16
15467829
Diabetes. 2002 Feb;51(2):271-5
11812732
Curr Opin Clin Nutr Metab Care. 2003 Nov;6(6):621-9
14557791
Neuroendocrinology. 2004;79(6):338-45
15273421
J Biol Chem. 1960 Sep;235:2595-9
13817286
Physiol Behav. 2004 Dec 30;83(4):573-8
15621062
J Clin Invest. 1999 Oct;104(7):975-82
10510338
Neurosci Biobehav Rev. 2001 Mar;25(2):167-74
11323081
Brain Res. 2000 Jul 28;872(1-2):64-70
10924676
J Clin Endocrinol Metab. 2006 Feb;91(2):718-21
16303834
Cell Mol Neurobiol. 2005 Aug;25(5):869-80
16133939
Peptides. 2005 Oct;26(10):1728-32
15993514
Brain Res. 2002 Mar 8;929(2):175-80
11864622
Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E838-45
11001766
J Clin Endocrinol Metab. 2001 Jan;86(1):422-6
11232034
Physiol Behav. 2006 Jun 30;88(3):244-8
16781741
Endocrine. 2002 Dec;19(3):327-32
12624434
J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):9-23
9869359
Brain Res. 1991 May 31;550(1):101-7
1653632
Endocrinology. 2006 Jun;147(6):2664-9
16556761
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4569-74
10200303
Brain Res. 1996 Oct 14;736(1-2):16-27
8930304
Biochem J. 2005 Jun 15;388(Pt 3):929-39
15715521
Ageing Res Rev. 2004 Nov;3(4):445-64
15541711
Cell Mol Neurobiol. 2003 Feb;23(1):1-25
12701881
Neuroendocrinology. 2007;86(3):191-209
17878708
Eur J Pharmacol. 2004 Apr 19;490(1-3):59-70
15094073
Exp Biol Med (Maywood). 2001 Dec;226(11):963-77
11743131
Diabetes. 1991 Nov;40(11):1397-403
1936601
Front Neuroendocrinol. 2003 Jan;24(1):1-10
12609497
Endocrinology. 1990 Dec;127(6):3234-6
2249648
Diabetes. 2000 Sep;49(9):1525-33
10969837
Cell Mol Neurobiol. 2005 Sep;25(6):995-1008
16392032
Obes Res. 2002 Sep;10(9):956-63
12226145
J Neurochem. 2007 May;101(3):757-70
17448147
Diabetologia. 2003 Dec;46(12):1629-40
14600817
Physiol Behav. 1997 Oct;62(4):767-72
9284495
Annu Rev Psychol. 2008;59:55-92
18154499
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E258-67
16403782
J Clin Invest. 2001 Oct;108(7):963-4
11581296